Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02006680 · ClinicalTrials.gov registry record
Markers of Pubertal Suppression During Therapy for Precocious Puberty
A clinical trial, sponsored by University of Minnesota.
- Terminated
- Registry status
- 4
- Enrollment target
NCT02006680 is a clinical trial that was terminated before completion, run by University of Minnesota. The registered enrollment target is 4 participants.
The verdict
NCT02006680 was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The best way to measure whether treatment of children with central precocious puberty is working is to do a hormone stimulation test (leuprolide stimulation test) that requires injection of a medication and multiple blood draws to see if the hormonal response is suppressed (blocked). The hypothesis of this study is that random measurement of the free alpha subunit of pituitary glycoprotein, a protein related to the pituitary hormones that stimulate puberty, will provide an adequate alternative to the leuprolide stimulation testfor monitoring efficacy of pubertal suppression with Supprelin LA®.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02006680
The ClinicalTrials.gov registry entry for NCT02006680 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02006680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02006680 about?
NCT02006680 is a clinical study titled "Markers of Pubertal Suppression During Therapy for Precocious Puberty". The best way to measure whether treatment of children with central precocious puberty is working is to do a hormone stimulation test (leuprolide stimulation test) that requires injection of a medication and multiple blood draws to see if the hormonal response is suppressed (blocked). The hypothesis ...
What is the current status of trial NCT02006680?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2013-12. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT02006680?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.